Â鶹AV

rsc.org
Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Cardiovascular Safety and State-of-the-art Development Issues: Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity

17 - 18 April 2012, Washington, DC, United States


Introduction
Join Industry Experts and Regulators to Improve Your Safety Analysis During Drug Development, Analyze and Mitigate Potential Risks, and Explore New Solutions and Approaches to Developing Safe and Effective Medications, including those to treat Type 2 Diabetes Mellitus.

Event Code:
12009

Useful links

Venue
Washington Marriott Hotel

Washington Marriott Hotel, Washington, DC, 20037, United States

Organised by
DIA
Contact information

Related events

7th International Conference on Nanomaterials Science and Mechanical Engineering

8 July 2025 08:00 - 11 July 2025 18:00, Aveiro, Portugal

Drugging the Multimorbidity Associated with Ageing

17 January 2025 09:30-17:00, London, United Kingdom

Future Labs Live Basel

27 May 2025 09:00 - 28 May 2025 17:00, Basel, Switzerland

21st Â鶹AV Nucleic Acids Forum – 2025

11 July 2025 10:00-18:00, London, United Kingdom


Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


X Close
E-mail Enquiry
*
*
*
*


Explore
Membership
Queens award
© Â鶹AV 2024
Registered charity number: 207890